At a glance
ClinicalIndex Comparison Record- ✓Confirmed bipolar disorder diagnosis per DSM-5
- ✓Depression severity ≥18 on MADRS (Montgomery-Åsberg Depression Rating Scale)
- ✓Currently on stable mood-stabilizing medication for ≥2 weeks
- ✕Any comorbid psychiatric disorder
- ✕Significant risk of suicide or self-harm
- ✕Any contraindication to tDCS, including implanted electronic medical devices
- ✕History of epilepsy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Community-based Transcranial Direct Current Stimulation Treatment for Bipolar Depression
In Brief
A clinical study evaluating Transcranial Direct Current Stimulation for Depression, Bipolar and 3 related conditions. Completed, enrolled 44 participants across 1 site.
Detailed Summary
Bipolar disorder is a severe and disabling disorder. The course of illness is often progressive but is highly heterogeneous between individuals and within the lifetime for an individual. The most common treatments are medications. However, for many individuals, combinations of medications are often required, and full recovery is infrequent. The novel brain stimulation treatment, transcranial direct current stimulation (tDCS), is a potential first-line treatment for bipolar depression. The present research question is whether tDCS can be provided as a home-based treatment for bipolar depression for adults with bipolar disorder.
Study Details
Timeline
Interventions
tDCS at 2mA in 30 minute sessions for 5 sessions per week for 3 weeks and then 2 sessions per week for 3 weeks.